Arcadia Consumer Healthcare (Bansk Group-backed) Acquires Avrio Health Assets
June 5, 2023
Arcadia Consumer Healthcare, a Bansk Group-backed consumer healthcare platform, has acquired substantially all of the assets of Avrio Health L.P., adding brands including Betadine, Colace, Senokot and SlowMag to its portfolio. The transaction is intended to expand Arcadia's product offerings and leverage its omni-channel distribution and retail relationships to drive growth.
- Buyers
- Arcadia Consumer Healthcare, Bansk Group
- Targets
- Avrio Health L.P.
- Sellers
- Avrio Health L.P.
- Platforms
- Arcadia Consumer Healthcare
- Industry
- Consumer Products
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Bansk Group Acquires Arcadia Consumer Healthcare from Avista Capital Partners
September 10, 2021
Consumer Products
Bansk Group, a New York-based private investment firm focused on consumer brands, agreed to acquire Arcadia Consumer Healthcare, a U.S. consumer health platform known for OTC medicines and premium vitamins and supplements, from Avista Capital Partners. The transaction (announced Aug. 9, 2021 and completed Sept. 10, 2021) positions Bansk to expand its consumer health and wellness portfolio and accelerate brand-building and M&A-driven growth.
-
Arcadia Consumer Healthcare Acquires NATURELO
October 15, 2020
Consumer Products
Arcadia Consumer Healthcare, a portfolio company of Avista Capital Partners, has acquired NATURELO, a premium vitamins, minerals and supplements (VMS) brand. The add-on expands Arcadia's product portfolio and online presence in the growing self-directed wellness market; financial terms were not disclosed.
-
Bansk Group Extends Investment in Arcadia Consumer Healthcare via Continuation Fund
January 20, 2026
Consumer Products
Bansk Group closed a continuation fund to extend its partnership with Arcadia Consumer Healthcare, with the transaction co-led by Coller Capital and Ares Secondaries Funds and supported by investment funds managed by BlackRock, Churchill, Dextra Partners, and Future Standard. The continuation structure provided liquidity to existing investors and supplies capital to accelerate Arcadia's organic and inorganic growth across its portfolio of OTC medicines, vitamins, and personal care brands.
-
Astorg Acquires Majority Stake in Avania
June 20, 2022
Healthcare Services
Astorg has acquired a majority stake in Avania from Kester Capital, with Kester expected to retain a minority position and management also reinvesting. Avania, a Bilthoven-headquartered MedTech-focused clinical CRO, will use Astorg's capital and network to accelerate organic growth and pursue M&A to build a scaled, global MedTech CRO platform.
-
Arcadia Acquires Selected Assets of Massachusetts eHealth Collaborative
April 30, 2020
Healthcare Services
Arcadia has acquired selected assets, technology and significant customer accounts from the Massachusetts eHealth Collaborative (MAeHC), a non-profit health IT services firm. The deal adds interoperability and data analytics capabilities and brings MAeHC leadership and talent, including Micky Tripathi, into Arcadia to expand its value-based care and population health offerings.
-
Arcadia Consumer Healthcare Acquires U.S. Rights to Kaopectate from Sanofi
March 20, 2020
Consumer Products
Arcadia Consumer Healthcare, a PE-backed consumer healthcare company, has acquired the U.S. rights to the Kaopectate over-the-counter anti-diarrheal brand from Sanofi. Backed by Avista Capital Partners, Arcadia said it will invest in marketing and innovation to grow the long-established Kaopectate franchise across major U.S. retailers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.